I disagree, the fundamentals have changed.
At the first hurdle involving humans the product fell over. Humans decided the risk wasn't worth the reward. And we learned that the trial designers, who I imagine were overseen by management failed to design a study that would attract patients.
It's not a great start and brings in to question the competency of all involved.
The product, however good it is, is useless without the right people to make it happen. Concentrating and believing in just the product isn't enough.
- Forums
- ASX - By Stock
- IBX
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-38
-
-
- There are more pages in this discussion • 187 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $1.364M |
Open | High | Low | Value | Volume |
3.9¢ | 3.9¢ | 3.9¢ | $2.423K | 62.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20739 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 4089 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20739 | 0.039 |
1 | 35000 | 0.038 |
1 | 100000 | 0.034 |
1 | 90000 | 0.033 |
1 | 32255 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 4089 | 1 |
0.055 | 188 | 1 |
0.056 | 6320 | 1 |
0.057 | 60000 | 1 |
0.058 | 14821 | 1 |
Last trade - 11.48am 02/08/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |